UBS Group’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-153,473
Closed -$6.08M 9017
2024
Q1
$6.08M Buy
153,473
+87,666
+133% +$3.48M ﹤0.01% 2019
2023
Q4
$1.25M Buy
65,807
+46,760
+245% +$891K ﹤0.01% 3266
2023
Q3
$218K Sell
19,047
-26,803
-58% -$307K ﹤0.01% 4215
2023
Q2
$471K Buy
45,850
+37,857
+474% +$389K ﹤0.01% 3873
2023
Q1
$61.7K Buy
7,993
+5,717
+251% +$44.1K ﹤0.01% 5208
2022
Q4
$16.7K Buy
+2,276
New +$16.7K ﹤0.01% 6696
2022
Q3
Sell
-1,200
Closed -$10K 9933
2022
Q2
$10K Sell
1,200
-1,169
-49% -$9.74K ﹤0.01% 6995
2022
Q1
$22K Sell
2,369
-2,627
-53% -$24.4K ﹤0.01% 6323
2021
Q4
$70K Buy
4,996
+3,854
+337% +$54K ﹤0.01% 5544
2021
Q3
$12K Buy
+1,142
New +$12K ﹤0.01% 6661
2021
Q2
Sell
-689
Closed -$7K 8698
2021
Q1
$7K Buy
+689
New +$7K ﹤0.01% 7139
2020
Q4
Sell
-1,404
Closed -$12K 7721
2020
Q3
$12K Buy
1,404
+288
+26% +$2.46K ﹤0.01% 5842
2020
Q2
$11K Buy
+1,116
New +$11K ﹤0.01% 6111
2019
Q3
Sell
-1,129
Closed -$5K 7225
2019
Q2
$5K Buy
1,129
+866
+329% +$3.84K ﹤0.01% 6522
2019
Q1
$2K Sell
263
-1,413
-84% -$10.7K ﹤0.01% 6639
2018
Q4
$6K Buy
+1,676
New +$6K ﹤0.01% 6571
2018
Q3
Sell
-2,137
Closed -$16K 7220
2018
Q2
$16K Buy
2,137
+1,107
+107% +$8.29K ﹤0.01% 5937
2018
Q1
$8K Buy
+1,030
New +$8K ﹤0.01% 6131
2017
Q3
Sell
-1,445
Closed -$14K 6942
2017
Q2
$14K Buy
+1,445
New +$14K ﹤0.01% 5614
2016
Q4
Sell
-530
Closed -$17K 6939
2016
Q3
$17K Buy
530
+528
+26,400% +$16.9K ﹤0.01% 5538
2016
Q2
$0 Buy
+2
New ﹤0.01% 6959